CCL Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine Vielzahl von CCL-Antikörpern für die Untersuchung der CCL-Familie von Chemokinen. CCL-Antikörper sind mit zahlreichen Forschungsanwendungen kompatibel, darunter Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit Paraffin eingebetteten Schnitten (IHCP), Durchflusszytometrie (FCM) und Enzyme-Linked Immunosorbent Assay (ELISA). CCL-Proteine spielen eine entscheidende Rolle bei der Immunantwort, indem sie die Migration und Aktivierung von Immunzellen vermitteln. CCL-Chemokine sind an verschiedenen physiologischen Prozessen beteiligt, unter anderem an Entzündungen, Gewebereparaturen und der Entwicklung von immunbedingten Krankheiten. Das Verständnis der Funktion des CCL-Proteins ist für die Entwicklung von therapeutischen Strategien in der Immunologie und Onkologie von entscheidender Bedeutung. Forscher auf der ganzen Welt verlassen sich auf monoklonale CCL-Antikörper, um neue Erkenntnisse über Chemokin-Signalwege zu gewinnen. Monoklonale CCL-Antikörper ermöglichen eine detaillierte Untersuchung der zellulären Mechanismen und des Krankheitsverlaufs. Die monoklonalen Antikörper von Santa Cruz Biotechnology unterstützen Forscher dabei, sinnvolle Beiträge zu wissenschaftlichen Erkenntnissen zu leisten.
Siehe auch...
ChemCruz™ Chemikalien CCL Inhibitors für die funktionelle Analyse zellulärer Antworten auf CCL
CCL Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
CCL14 Antikörper (E-12) | sc-376152 | mouse IgG1 κ | 65-93 (h) | WB, IP, IF, IHC(P), ELISA | h | neu | ||
CCL14 Antikörper (E-5) | sc-28388 | mouse IgG2b κ | 22-93 (h) | WB, IP, IF, IHC(P), ELISA | h | 2 | ||
CCL14 Antikörper (E-1) | sc-390652 | mouse IgG1 κ | 60-93 (h) | WB, IP, IF, ELISA | h | neu | ||
CCL23 Antikörper (H-2) | sc-393897 | mouse IgG1 κ | 26-49 (h) | WB, IP, IF, ELISA | h | 1 | ||
CCL27 Antikörper (G-6) | sc-390112 | mouse IgG1 κ | 85-109 (h) | WB, IP, IF, ELISA | m, r, h | 2 | ||
CCL27 Antikörper (DR33) | sc-73787 | rat IgG2a | FL (m) | WB, IP, IF, IHC(P), ELISA | m | neu | ||
CCL27 Antikörper (49-78) | sc-73786 | mouse IgG1 | FL (h) | WB, IF, IHC(P), ELISA | h | neu | ||
CCL28 Antikörper (G-2) | sc-376654 | mouse IgG1 κ | 103-130 (m) | WB, IP, IF, ELISA | m | 3 |
CCL CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
CCL14 CRISPR/Cas9 KO Plasmid (h) | sc-406423 | h | Gene Knockout | GFP | 0 | ||
CCL14 HDR Plasmid (h2) | sc-406423-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
CCL14 Double Nickase Plasmid (h) | sc-406423-NIC | h | Gene Knockout | Puromycin | 0 | ||
CCL14 Double Nickase Plasmid (h2) | sc-406423-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
CCL23 CRISPR/Cas9 KO Plasmid (h) | sc-408772 | h | Gene Knockout | GFP | 0 | ||
CCL23 HDR Plasmid (h) | sc-408772-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
CCL23 Double Nickase Plasmid (h) | sc-408772-NIC | h | Gene Knockout | Puromycin | 0 | ||
CCL23 Double Nickase Plasmid (h2) | sc-408772-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
CCL27 CRISPR/Cas9 KO Plasmid (h) | sc-417708 | h | Gene Knockout | GFP | 0 | ||
CCL27 HDR Plasmid (h) | sc-417708-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
CCL27 Double Nickase Plasmid (h) | sc-417708-NIC | h | Gene Knockout | Puromycin | 0 | ||
CCL27 Double Nickase Plasmid (h2) | sc-417708-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
CCL27 CRISPR/Cas9 KO Plasmid (m) | sc-422842 | m | Gene Knockout | GFP | 0 | ||
CCL27 Double Nickase Plasmid (m) | sc-422842-NIC | m | Gene Knockout | Puromycin | 0 | ||
CCL27 Double Nickase Plasmid (m2) | sc-422842-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
CCL27b CRISPR/Cas9 KO Plasmid (m) | sc-437202 | m | Gene Knockout | GFP | 0 | ||
CCL27b HDR Plasmid (m) | sc-437202-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
CCL27b Double Nickase Plasmid (m) | sc-437202-NIC | m | Gene Knockout | Puromycin | 0 | ||
CCL27b Double Nickase Plasmid (m2) | sc-437202-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
CCL28 CRISPR/Cas9 KO Plasmid (h) | sc-408264 | h | Gene Knockout | GFP | 0 | ||
CCL28 HDR Plasmid (h) | sc-408264-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
CCL28 Double Nickase Plasmid (h) | sc-408264-NIC | h | Gene Knockout | Puromycin | 0 | ||
CCL28 Double Nickase Plasmid (h2) | sc-408264-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
CCL28 CRISPR/Cas9 KO Plasmid (m) | sc-425317 | m | Gene Knockout | GFP | 0 | ||
CCL28 HDR Plasmid (m) | sc-425317-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
CCL28 Double Nickase Plasmid (m) | sc-425317-NIC | m | Gene Knockout | Puromycin | 0 | ||
CCL28 Double Nickase Plasmid (m2) | sc-425317-NIC-2 | m | Gene Knockout | Puromycin | 0 |
CCL CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
CCL14 CRISPR Activation Plasmid (h) | sc-406423-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL14 CRISPR Activation Plasmid (h2) | sc-406423-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL14 Lentiviral Activation Particles (h) | sc-406423-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL14 Lentiviral Activation Particles (h2) | sc-406423-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL23 CRISPR Activation Plasmid (h) | sc-408772-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL23 CRISPR Activation Plasmid (h2) | sc-408772-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL23 Lentiviral Activation Particles (h) | sc-408772-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL23 Lentiviral Activation Particles (h2) | sc-408772-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL27 CRISPR Activation Plasmid (h) | sc-417708-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL27 CRISPR Activation Plasmid (h2) | sc-417708-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL27 Lentiviral Activation Particles (h) | sc-417708-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL27 Lentiviral Activation Particles (h2) | sc-417708-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL27 CRISPR Activation Plasmid (m) | sc-422842-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL27 CRISPR Activation Plasmid (m2) | sc-422842-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL27 Lentiviral Activation Particles (m) | sc-422842-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL27 Lentiviral Activation Particles (m2) | sc-422842-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL27b CRISPR Activation Plasmid (m) | sc-437202-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL27b CRISPR Activation Plasmid (m2) | sc-437202-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL27b Lentiviral Activation Particles (m) | sc-437202-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL27b Lentiviral Activation Particles (m2) | sc-437202-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL28 CRISPR Activation Plasmid (h) | sc-408264-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL28 CRISPR Activation Plasmid (h2) | sc-408264-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL28 Lentiviral Activation Particles (h) | sc-408264-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL28 Lentiviral Activation Particles (h2) | sc-408264-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL28 CRISPR Activation Plasmid (m) | sc-425317-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL28 CRISPR Activation Plasmid (m2) | sc-425317-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL28 Lentiviral Activation Particles (m) | sc-425317-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CCL28 Lentiviral Activation Particles (m2) | sc-425317-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
CCL siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
CCL14 siRNA (h) | sc-45580 | h | Gene Silencing | N/A | 1 | ||
CCL14 shRNA Plasmid (h) | sc-45580-SH | h | Gene Silencing | Puromycin | 1 | ||
CCL14 shRNA (h) Lentivirale Partikel | sc-45580-V | h | Gene Silencing | Puromycin | 1 | ||
CCL23 siRNA (h) | sc-45634 | h | Gene Silencing | N/A | 0 | ||
CCL23 shRNA Plasmid (h) | sc-45634-SH | h | Gene Silencing | Puromycin | 0 | ||
CCL23 shRNA (h) Lentivirale Partikel | sc-45634-V | h | Gene Silencing | Puromycin | 0 | ||
CCL27 siRNA (h) | sc-39346 | h | Gene Silencing | N/A | 0 | ||
CCL27 shRNA Plasmid (h) | sc-39346-SH | h | Gene Silencing | Puromycin | 0 | ||
CCL27 shRNA (h) Lentivirale Partikel | sc-39346-V | h | Gene Silencing | Puromycin | 0 | ||
CCL27 siRNA (m) | sc-39347 | m | Gene Silencing | N/A | 1 | ||
CCL27 shRNA Plasmid (m) | sc-39347-SH | m | Gene Silencing | Puromycin | 1 | ||
CCL27 shRNA (m) Lentivirale Partikel | sc-39347-V | m | Gene Silencing | Puromycin | 1 | ||
CCL27b siRNA (m) | sc-144764 | m | Gene Silencing | N/A | 0 | ||
CCL27b shRNA Plasmid (m) | sc-144764-SH | m | Gene Silencing | Puromycin | 0 | ||
CCL27b shRNA (m) Lentivirale Partikel | sc-144764-V | m | Gene Silencing | Puromycin | 0 | ||
CCL28 siRNA (h) | sc-72144 | h | Gene Silencing | N/A | 0 | ||
CCL28 shRNA Plasmid (h) | sc-72144-SH | h | Gene Silencing | Puromycin | 0 | ||
CCL28 shRNA (h) Lentivirale Partikel | sc-72144-V | h | Gene Silencing | Puromycin | 0 | ||
CCL28 siRNA (m) | sc-72145 | m | Gene Silencing | N/A | 0 | ||
CCL28 shRNA Plasmid (m) | sc-72145-SH | m | Gene Silencing | Puromycin | 0 | ||
CCL28 shRNA (m) Lentivirale Partikel | sc-72145-V | m | Gene Silencing | Puromycin | 0 |